|
Market Closed -
Toronto S.E.
15:40:12 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 29.56 CAD | +1.97% |
|
+5.76% | +16.88% |
| 08-19 | Gilead Sciences Insider Sold Shares Worth $3,853,908, According to a Recent SEC Filing | MT |
| 08-11 | Global drugmakers invest billions to boost US presence | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,119B | |||||
| 651B | - | - | - | ||
| 468B | |||||
| 374B | |||||
| 302B |
Select your edition
All financial news and data tailored to specific country editions
